Clinical Trials Browser

Meningeal Carcinomatosis × Deferoxamine × 90 days × Clear all

NCT05184816 2026-03-27

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

Phase 1 Recruiting

Recurrence, Meningeal Carcinomatosis